Rosuvastatin + Amlodipine
Rosuvastatin/Amlodipine Teva contains two active substances - rosuvastatin and amlodipine.
Rosuvastatin belongs to a group of medicines called statins, and amlodipine belongs to a group of medicines called calcium channel blockers.
Rosuvastatin is used to correct the level of fatty substances in the blood called lipids, the most common of which is cholesterol. High cholesterol levels can cause fatty deposits to build up in the walls of blood vessels, causing them to narrow. By lowering cholesterol levels, the risk of heart attack, stroke, or other health problems caused by narrowed blood vessels can be reduced.
Amlodipine is used to treat high blood pressure. It widens the blood vessels, making it easier for blood to flow through them.
Rosuvastatin/Amlodipine Teva is indicated for the treatment of high blood pressure and high cholesterol in adult patients when diet and physical activity have not been sufficient to lower cholesterol levels.
Rosuvastatin/Amlodipine Teva is also indicated for the prevention of cardiovascular events if there are other factors that increase the risk of heart attack, stroke, or related health disorders.
Rosuvastatin/Amlodipine Teva is indicated for patients who are already taking rosuvastatin and amlodipine in the same doses as in Rosuvastatin/Amlodipine Teva. Patients already taking rosuvastatin and amlodipine in separate tablets may take one tablet of Rosuvastatin/Amlodipine Teva, which contains both active substances in the same doses.
During treatment with Rosuvastatin/Amlodipine Teva, the patient should continue to follow a cholesterol-lowering diet and exercise.
Before starting treatment with Rosuvastatin/Amlodipine Teva, the patient should discuss it with their doctor or pharmacist:
A small number of people taking statins may experience liver problems. This can be determined by a simple blood test that shows increased liver enzyme activity. For this reason, the doctor usually performs a blood test (liver function tests) before and during treatment with Rosuvastatin/Amlodipine Teva.
Severe skin reactions, including Stevens-Johnson syndrome and drug rash with eosinophilia and systemic symptoms (DRESS), have been reported with Rosuvastatin/Amlodipine Teva. If any of the symptoms described in section 4 occur, the patient should stop taking Rosuvastatin/Amlodipine Teva and contact their doctor immediately.
Patients with diabetes or those at risk of developing diabetes will be closely monitored by their doctor while taking this medicine. People with high sugar and fat levels in the blood, overweight, and high blood pressure may be at risk of developing diabetes.
Rosuvastatin/Amlodipine Teva should not be taken by children and adolescents.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Rosuvastatin/Amlodipine Teva may affect the action of other medicines or other medicines may affect the action of Rosuvastatin/Amlodipine Teva:
If it is necessary to take fusidic acid to treat a bacterial infection, the patient should stop taking Rosuvastatin/Amlodipine Teva during this time. The doctor will inform the patient when it is safe to restart taking Rosuvastatin/Amlodipine Teva. Taking Rosuvastatin/Amlodipine Teva with fusidic acid may rarely lead to weakness, sensitivity, or muscle pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4.
Rosuvastatin/Amlodipine Teva may further lower blood pressure in patients already taking other antihypertensive medicines.
Rosuvastatin/Amlodipine Teva can be taken with or without food.
Patients taking Rosuvastatin/Amlodipine Teva should not drink grapefruit juice or eat grapefruits, as grapefruits and grapefruit juice may increase the level of the active substance amlodipine in the blood, which may cause an unexpected increase in the blood pressure-lowering effect of Rosuvastatin/Amlodipine Teva.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Rosuvastatin/Amlodipine Teva should not be taken during pregnancy or breastfeeding.
If the patient becomes pregnant while taking Rosuvastatin/Amlodipine Teva, they should stop taking the medicine and contact their doctor. Women of childbearing age should use effective methods of contraception while taking Rosuvastatin/Amlodipine Teva.
Before taking any medicine, the patient should consult their doctor or pharmacist.
Rosuvastatin/Amlodipine Teva may affect the patient's ability to drive and use machines. Some patients may experience dizziness when taking Rosuvastatin/Amlodipine Teva. If the medicine causes nausea, dizziness, fatigue, or headache, the patient should not drive or operate machinery and should contact their doctor immediately.
This medicine contains less than 1 mmol (23 mg) of sodium per capsule, which means it is considered "sodium-free".
This medicine should always be taken as directed by the doctor or pharmacist. If the patient has any doubts, they should consult their doctor or pharmacist.
The recommended dose of the medicine is one capsule per day.
The medicine can be taken before or after a meal. The medicine should be taken at the same time every day, with a glass of water. The patient should not take Rosuvastatin/Amlodipine Teva with grapefruit juice.
Rosuvastatin/Amlodipine Teva should not be taken by children and adolescents.
It is essential to visit the doctor for regular cholesterol level checks to ensure that the level has reached and maintained the appropriate values.
The patient should contact their doctor or the nearest hospital for advice. Taking too many tablets may cause low or even dangerously low blood pressure. The patient may experience dizziness, fainting, or weakness. If the blood pressure drop is significant, it may lead to shock. The patient's skin may become cold and clammy, and they may lose consciousness. If the patient goes to the hospital or receives treatment for another illness, they should inform the medical staff that they are taking Rosuvastatin/Amlodipine Teva.
Excess fluid may accumulate in the lungs (pulmonary edema), causing shortness of breath, which may occur within 24-48 hours after taking the medicine.
There is no need to worry. If the patient forgets to take a capsule, they should skip that dose and take the next dose at the usual time. The patient should not take a double dose to make up for the missed dose.
The doctor will determine how long the patient should take the medicine. Stopping treatment with Rosuvastatin/Amlodipine Teva may cause cholesterol levels to rise again. If the patient stops taking the medicine earlier than recommended by their doctor, the disease may return.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Rosuvastatin/Amlodipine Teva can cause side effects, although not everyone gets them.
If the patient experiences any of the following serious side effects, they should stop taking the medicine and contact their doctor immediately:
SIDE EFFECTS ASSOCIATED WITH ROSUVASTATIN
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
SIDE EFFECTS ASSOCIATED WITH AMLODIPINE
If the patient experiences any of the following side effects, or if they get worse or last longer than a week, they should contact their doctor:
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
The following list includes other reported side effects. If any of the following side effects worsen or if side effects not listed in the leaflet occur, the patient should inform their doctor or pharmacist:
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
If the patient experiences any side effects not listed in the leaflet, they should inform their doctor or pharmacist.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309; Website: https://smz.ezdrowie.gov.pl; Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not take this medicine after the expiry date stated on the packaging after "EXP".
The expiry date refers to the last day of the month stated.
Store in a temperature below 30°C. Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are rosuvastatin (in the form of rosuvastatin calcium) and amlodipine (in the form of amlodipine besylate).
10 mg + 5 mg: Each hard capsule contains 10 mg of rosuvastatin (in the form of rosuvastatin calcium) and 5 mg of amlodipine (in the form of amlodipine besylate).
10 mg + 10 mg: Each hard capsule contains 10 mg of rosuvastatin (in the form of rosuvastatin calcium) and 10 mg of amlodipine (in the form of amlodipine besylate).
20 mg + 5 mg: Each tablet contains 20 mg of rosuvastatin (in the form of rosuvastatin calcium) and 5 mg of amlodipine (in the form of amlodipine besylate).
20 mg + 10 mg: Each tablet contains 20 mg of rosuvastatin (in the form of rosuvastatin calcium) and 10 mg of amlodipine (in the form of amlodipine besylate).
Other ingredients are:
Capsule contents:cornstarch (including pregelatinized cornstarch), microcrystalline cellulose type 102, crospovidone (type A), sodium stearyl fumarate (see section 2 "Rosuvastatin/Amlodipine Teva contains sodium")
Capsule shell: gelatin, titanium dioxide (E 171)
Red ink: shellac (E 904), propylene glycol (E 1520), ammonium hydroxide, iron oxide red (E 172), potassium hydroxide
Green ink: shellac, titanium dioxide (E 171), indigo carmine (E 132), iron oxide yellow (E 172), ammonium hydroxide, propylene glycol
10 mg + 5 mg
A hard gelatin capsule, size 1, with a white opaque body with a red print "Aml 5 mg" and a white opaque cap with a green print "Rsv 10 mg".
10 mg + 10 mg
A hard gelatin capsule, size 00, with a white opaque body with a line and a red print "Aml 10 mg" and a white opaque cap with a green print "Rsv 10 mg".
20 mg + 5 mg
A hard gelatin capsule, size 00, with a white opaque body with a red print "Aml 5 mg" and a white opaque cap with a line and a green print "Rsv 20 mg".
20 mg + 10 mg
A hard gelatin capsule, size 00, with a white opaque body with a line and a red print "Aml 10 mg" and a white opaque cap with a line and a green print "Rsv 20 mg".
Rosuvastatin/Amlodipine Teva is available in PA/Aluminum/PVC/Aluminum blisters containing 10, 28, 30, and 100 hard capsules.
Not all pack sizes may be marketed.
Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands
Balkanpharma-Dupnitsa AD
3-Samokovsko Shosse Str.,
Dupnitsa 2600, Bulgaria
Ludwig-Merckle-Strasse 3,
89143 Blaubeuren
Germany
Date of last revision of the leaflet:June 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.